Zhi-jun Y. Sun
State Key Laboratory Of Oral & Maxillofacial Reconstruction And Regeneration, Key Laboratory Of Oral Biomedicine Ministry Of Education, Hubei Key Laboratory Of Stomatology
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Orchestrating mast cell for cancer immunotherapy.
Journal: International immunopharmacology
Published: March 13, 2026
Erratum: AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Journal: American journal of translational research
Published: February 02, 2026
Targeting erythroid progenitor cell metabolism to enhance cancer immunotherapy.
Journal: NPJ precision oncology
Published: November 23, 2025
Harnessing Cuproptosis resistance to advance cancer therapeutics.
Journal: Apoptosis : an international journal on programmed cell death
Published: November 12, 2025
Correction: Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
Journal: Cellular and molecular life sciences : CMLS
Published: November 07, 2025
Erratum: B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.
Journal: American journal of translational research
Published: October 22, 2025
Tuning tissue-resident memory T cells to fuel cancer immunotherapy.
Journal: International immunopharmacology
Published: September 30, 2025
Leveraging macrophage plasticity for precision-targeted tumor immunotherapy.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 24, 2025
Targeting cuproptosis with nanomaterials for cancer immunotherapy.
Journal: Acta biomaterialia
Published: July 08, 2025
Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy.
Journal: Theranostics
Published: June 05, 2025
Correction: Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma.
Journal: Cellular and molecular life sciences : CMLS
Published: May 31, 2025
Last Updated: 09/26/2026